COVID-19 항체 검출 키트 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global COVID-19 antibody detection kit market size is expected to reach USD 17.42 Billion in 2034 from USD 8.96 Billion in 2025, growing at a CAGR of 7.67 during 2026-2034.This market continues to evolve as healthcare systems emphasize disease surveillance, immunity assessment, and pandemic preparedness. COVID-19 antibody detection kits gained widespread adoption during the pandemic and remain valuable for monitoring immune responses following infection or vaccination. Growing awareness regarding infectious disease management and the need for rapid diagnostic tools are supporting market demand. Healthcare providers increasingly rely on antibody testing to support epidemiological studies and public health monitoring programs.

Technological advancements in diagnostic platforms have improved the accuracy, speed, and accessibility of antibody detection kits. The growing integration of laboratory automation and point-of-care testing solutions is enhancing testing efficiency across healthcare facilities. Research institutions and governments are investing in infectious disease monitoring initiatives, contributing to continued demand. Additionally, lessons learned from the pandemic have strengthened investments in diagnostic infrastructure and preparedness measures worldwide.

The market is expected to maintain steady growth through diversification into broader infectious disease testing applications. Future opportunities are likely to emerge from multiplex diagnostic kits capable of detecting multiple pathogens simultaneously. Innovations in biotechnology and immunology research will further improve testing accuracy and affordability. As healthcare systems prioritize preparedness against future outbreaks, antibody detection technologies are expected to remain an important component of global diagnostic strategies.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Kits

• Viral Load Testing Kits (qPCR and RT-PCR)
• Virus Neutralizing Assay Kits
• Antibody Detection Kits (ELISA)
• Viral Antigen Detection Test Kits
• Other Kits

By Consumables

• Swabs
• Tubes
• Viral Transfer Media
• Reagents
• Other Consumables

By Specimen Type

• Nose & Throat Swab
• Blood
• Sputum
• Nasal Aspirate

By End Use

• Hospitals
• Clinics
• Public Health Labs
• Private and Commercial Labs
• Physicians Labs
• Research Institutes
• Other End Uses

COMPANIES PROFILED

• Cepheid, BGI Genomics, Abbott Laboratories, bioMerieux SA, Bio-Rad Laboratories, F. Hoffmann-La Roche, GenMark Diagnostics, Mylab Discovery Solutions, Qiagen, Quidel Corporation, Randox Laboratories, SD Biosensor

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COVID-19 ANTIBODY DETECTION KIT MARKET: BY KITS 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Kits
• 4.2. Viral Load Testing Kits (qPCR and RT-PCR) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Virus Neutralizing Assay Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Antibody Detection Kits (ELISA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Viral Antigen Detection Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COVID-19 ANTIBODY DETECTION KIT MARKET: BY CONSUMABLES 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Consumables
• 5.2. Swabs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Tubes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Viral Transfer Media Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COVID-19 ANTIBODY DETECTION KIT MARKET: BY SPECIMEN TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Specimen Type
• 6.2. Nose & Throat Swab Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Sputum Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Nasal Aspirate Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COVID-19 ANTIBODY DETECTION KIT MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Public Health Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Private and Commercial Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Physicians Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.8. Other End Uses Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL COVID-19 ANTIBODY DETECTION KIT MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Kits
  • 8.2.2 By Consumables
  • 8.2.3 By Specimen Type
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Kits
  • 8.3.2 By Consumables
  • 8.3.3 By Specimen Type
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Kits
  • 8.4.2 By Consumables
  • 8.4.3 By Specimen Type
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Kits
  • 8.5.2 By Consumables
  • 8.5.3 By Specimen Type
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Kits
  • 8.6.2 By Consumables
  • 8.6.3 By Specimen Type
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL COVID-19 ANTIBODY DETECTION KIT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Cepheid
  • 10.2.2 BGI Genomics
  • 10.2.3 Abbott Laboratories
  • 10.2.4 BioMerieux SA
  • 10.2.5 Bio-Rad Laboratories
  • 10.2.6 F. Hoffmann-La Roche
  • 10.2.7 GenMark Diagnostics
  • 10.2.8 Mylab Discovery Solutions
  • 10.2.9 Qiagen
  • 10.2.10 Quidel Corporation
  • 10.2.11 Randox Laboratories
  • 10.2.12 SD Biosensor